Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs Tempus AI (TEM) Price & Performance

Centene CorpTrade
Tempus AITrade

Price performance (Past 24H)

Key statistics

Centene Corp vs Tempus AI — how do they compare? Centene Corp trades at $68.55 (market cap $33.72B), while Tempus AI trades at $58.75 (market cap $10.04B). The key difference: Centene Corp is far larger — about 3.4× Tempus AI's market cap, and Centene Corp is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.

CNCTEM
Market Cap
$33.72B$10.04B
Sector
HealthBroad Market / Factor
52-Week High
$68.72$103.25
52-Week Low
$25.21$42.37
Enterprise Value
$26.35B$10.72B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.

Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.

Tempus AI

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM